Botulinum A toxin for the treatment of focal hyperhidrosis -5 cases-

국소화 다한증에 대해 보툴리늄 독소를 이용한 치료 -5례보고-

  • Lee, Song-Am (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University) ;
  • Kim, Kwang-Taik (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University) ;
  • Park, Sung-Min (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University) ;
  • Chung, Bong-Kyu (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University) ;
  • Sun, Kyung (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University) ;
  • Kim, Hyoung-Mook (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University) ;
  • Lee, IIn-Sung (Department of Thoracic and Cardiovascular Surgery, College of medicine, Korea University)
  • 이송암 (고려대학교 의과대학 흉부외과학교실) ;
  • 김광택 (고려대학교 의과대학 흉부외과학교실) ;
  • 박성민 (고려대학교 의과대학 흉부외과학교실) ;
  • 정봉규 (고려대학교 의과대학 흉부외과학교실) ;
  • 선경 (고려대학교 의과대학 흉부외과학교실) ;
  • 김형묵 (고려대학교 의과대학 흉부외과학교실) ;
  • 이인성 (고려대학교 의과대학 흉부외과학교실)
  • Published : 2000.03.01

Abstract

Thoracic sympathicotomy has been used safely and successfully to treat essential hyperhidrosis. However, it has been difficult to treat compansatory hyperhidrosis after thoracic sympathicotomy and focal hyperhidrosis. The sweat glands were innervated by post-ganglionic sympathetic fibers with acetylcholic serving as the transmitter. Botulinum A toxin has been reported to block neuro-transmission at the cholinergic autonomic nerve terminals. Prospecting its effect for the sweat gland, we treated 5 patients with focal hyperhidrosis with botulinum A toxin. Three patients received bilateral thoracic sympathectomy (1 case) and sympathicotomy(2 case) via VAT. The hyperhidrosis area was marked with betadine and was subdivided into squares of 2$\times$2 cm(4$\textrm{cm}^2$) each. Botulinum A toxin was injected intracutaneously in a dosage of 2.5U/0.1ml(100U/4ml) /4$\textrm{cm}^2$. A total dose of 100U of Botulinum A toxin was injected into the affected sites. Subjective assessment of sweat production by the patients using a visual analogue scale showed a 20~70% improvement. During the follow-up period, no toxic effects were observed.

Keywords

References

  1. 대흉외지 v.31 다한증 환자에서 2mm 흉강경 기구를 이용한 미용적 교간신경절제술 성숙환;최용수;조광리;김태영;김주현
  2. Trans Am Ophthalmol Soc v.79 no.734 Botulinum toxin injection of eye muscles to correct strabismus Scott AB
  3. Acta Otolaryngol v.115 Frey's Syndrome: treatment with botulinum toxin Drobik C;Laskawi R
  4. Mov Disord v.10 Botulinum toxin and sweating Bushara KO;Jones JW;Park DM;Schutta HS
  5. Br J Dermatol v.136 Double-blind trial of botulinum a toxin for the treatment of focal hyperhidrosis of the palm Schnider P;Binder M;Auff E;Kittler H;Berger T;Wolff K
  6. Ann Otol Rhinol Laryngol v.107 Botulinum toxin type A for Frey's syndrome: A preluninary prospective study Laccourreye O;Muscatelo L;Naude C;Bonan B;Brasnu D
  7. Ann Neurol v.42 Treatment of gustatory sweating with botulinum toxin Naccourreye O;Muscatelo L;Naude C;Bonan B;Brasnu D
  8. Laryngoscope v.108 Up-to-date report of botulunum toxin type A treatment in patients with guestatory sweating(Frey's syndrome) Laskawi R;Drobik C;Schonebeck C